18
Participants
Start Date
September 30, 2014
Primary Completion Date
May 31, 2025
Study Completion Date
May 31, 2025
Hypofractionated radiotherapy
Treatment of 3.4 Gy will be given daily 5 days per week over 2 weeks.
Temozolomide
During concomitant phase Temozolomide will be administered orally at 75 mg/m2 for 2 weeks concomitant with radiotherapy. During the adjuvant phase Temozolomide will be administered orally at 150 mg/m2 on days 1 through day 5 of each 28 day cycle for a maximum of 6 cycles.
James Graham Brown Cancer Center, Louisville
James Graham Brown Cancer Center
OTHER
University of Louisville
OTHER